ArticlePeerJ2026

A SUMOylation/immune-related gene signature predicts the prognosis and immunotherapy efficacy of patients with triple-negative breast cancer.

Pengcheng Zou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.